Luc Gagnon - Concepedia

Author

Luc Gagnon

Icahn School of Medicine at Mount Sinai

Also Known As

Luc Gagnon, St-Amant, Natalie

Publications

731

Citations

H-Index

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai The University of Texas Medical Branch at Galveston Duke University Inserm Institut Pasteur

About

Luc Gagnon is an author at Icahn School of Medicine at Mount Sinai specializing in covid-19, virology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	547
2	Covid-19	2	2	547
3	Immunology	1	1	317
4	Vaccine Development	1	1	230
5	Viral Immunity	1	1	317

Luc Gagnon

Publications

704

Citations

H-Index

Page 1

	Year	Citations
Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays Kevin R. Bewley, Naomi S. Coombes, Luc Gagnon, Nature Protocols Virus Neutralization AssaysViral DiagnosticsViral PathogenesisImmunologyAntiviral Response	2021	317
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial Scott A. Halperin, Lingyun Ye, Donna MacKinnon‐Cameron, The Lancet VaccinationVaccine SafetyVaccine DevelopmentVaccine TrialVirology	2021	230
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models Pauline Maisonnasse, Yoann Aldon, Aurélien Marc, Nature Communications	2021	54
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri, EClinicalMedicine	2022	54
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models Pauline Maisonnasse, Yoann Aldon, Aurélien Marc,	2021	20
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis Mark Manak, Luc Gagnon, Steven Phay-Tran, The Lancet Microbe	2024	17
Coronavirus Immunotherapeutic Consortium Database Jarjapu Mahita, Brendan Ha, Anaïs Gambiez, Database	2023	12

Page 1